Increasing Activity in Peripheral Arterial Disease
Increasing Activity in Peripheral Arterial Disease
批准号:
7372129
负责人:
Mary McGrae McDermott
金额:
$75.48万
依托单位国家:
美国
项目类别:
财政年份:
2008
资助国家:
美国
项目状态:
已结题
起止时间:
2008-04-01 至 2012-03-31
关键词:
AffectAgeAttentionBackBehavior TherapyBehavioralCharacteristicsClinicalClinical TrialsCognitiveCognitive TherapyCommunitiesCompetenceConditionDataExerciseFrequenciesGeneric DrugsGuidelinesHigh PrevalenceHome environmentHospitalizationImpairmentInsuranceInterventionLegLiving WillsLower ExtremityMaintenanceMeasuresMediatingMediator of activation proteinMedicalMedical centerNumbersNursing HomesOutcomeOutcome StudyPain in lower limbParticipantPatientsPerceptionPerformancePeripheral arterial diseasePersonsPhasePhysical FunctionPhysical activityPlacementPopulationQuality of lifeQuestionnairesRandomizedRateRehabilitation therapyRiskScoreSelf EfficacySiteSocial supportSpeedSymptomsTelephoneTestingTravelUnited StatesWalkingWeekWomanWorkbasebehavior measurementcostdaydesiredisabilityexperiencefollow-upfunctional declinefunctional disabilityfunctional outcomeshealth related quality of lifeimprovedindexingmenmortalitymultidisciplinaryolder patientpreventprogramssatisfactionskillstherapy design
中文摘要
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): Lower extremity peripheral arterial disease (PAD) affects 10% to 15% of community dwelling men and women age 65 and older. Our work and that of others show that patients with PAD have a higher prevalence of lower extremity functional impairment and increased rates of functional decline compared to persons without PAD. The specific functional impairments documented in persons with PAD are associated with increased risks of disability, nursing home placement, hospitalization, and mortality in community-dwelling populations. Supervised exercise rehabilitation programs improve treadmill walking performance in patients with PAD. However, few PAD patients have access to supervised exercise rehabilitation programs because of costs and barriers to the travel required back and forth to the exercise facility. Consequently, few PAD patients participate in supervised exercise programs. Current clinical guidelines for management of patients with PAD indicate that there are insufficient data to support home-based walking exercise programs in persons with PAD. A definitive clinical trial is needed to determine whether an intervention designed to increase home-based walking exercise improves lower extremity functioning in patients with PAD. The primary aim of this study is to determine whether an intervention designed to increase home-based walking exercise significantly improves six-minute walk performance in men and women with PAD. Our specific aims will be tested in 200 men and women with PAD. Our intervention employs a Group Mediated Cognitive Behavioral intervention to help patients with PAD overcome identified barriers and develop the skills necessary to engage in regular home walking exercise. A multidisciplinary team with internationally-recognized expertise in exercise, behavioral interventions, PAD, functional outcomes, and exercise rehabilitation has been assembled to carry out the proposed study. If a home-based walking exercise program significantly benefits patients with PAD, this finding will have significant implications for maintaining functioning and preventing functional decline in the large and growing number of men and women with PAD. Previous study shows that patients with lower extremity peripheral arterial disease (PAD) have greater functional impairment, increased rates of functional decline, and increased mobility loss compared to persons without PAD. Yet few therapies have been identified that improve lower extremity functioning or prevent functional decline or mobility loss in persons with PAD. Current clinical guidelines for management of patients with PAD indicate that there are insufficient data to support home-based walking exercise programs in persons with PAD. A definitive clinical trial is needed to determine whether an intervention designed to increase home-based walking exercise improves lower extremity functioning in patients with PAD. If a home-based walking exercise program significantly benefits patients with PAD, this finding will have significant implications for maintaining functioning and preventing functional decline in the large and growing number of men and women with PAD.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Far Red Light to Improve Functioning in PAD: the LIGHT PAD Trial
-
批准号:10572758
-
项目类别:
-
资助金额:$26.76万
-
财政年份:2023
-
负责人:Mary McGrae McDermott
-
依托单位:
Response to Exercise and Nitric Oxide in PAD: the RESIST PAD Trial
-
批准号:10656845
-
项目类别:
-
资助金额:$74.92万
-
财政年份:2023
-
负责人:Mary McGrae McDermott
-
依托单位:
ENhancing exercise with LIGHT to improve functioning in PAD: the ENLIGHTEN PAD Trial
-
批准号:10645929
-
项目类别:
-
资助金额:$26.75万
-
财政年份:2023
-
负责人:Mary McGrae McDermott
-
依托单位:
BEET root juice to reverse functional impairment in PAD: The BEET PAD Trial
-
批准号:10440812
-
项目类别:
-
资助金额:$73.98万
-
财政年份:2022
-
负责人:Mary McGrae McDermott
-
依托单位:
Sequential Multiple Assessment Randomized Trial of Exercise for PAD: SMART Exercise for PAD
-
批准号:10708097
-
项目类别:
-
资助金额:$67.16万
-
财政年份:2022
-
负责人:Mary McGrae McDermott
-
依托单位:
BEET root juice to reverse functional impairment in PAD: The BEET PAD Trial
-
批准号:10649671
-
项目类别:
-
资助金额:$65.7万
-
财政年份:2022
-
负责人:Mary McGrae McDermott
-
依托单位:
FIsetin to Reduce Senescence and mobility impairmenT in PAD: the FIRST Pilot Randomized Trial
-
批准号:10526851
-
项目类别:
-
资助金额:$22.25万
-
财政年份:2022
-
负责人:Mary McGrae McDermott
-
依托单位:
Sequential Multiple Assessment Randomized Trial of Exercise for PAD: SMART Exercise for PAD
-
批准号:10584209
-
项目类别:
-
资助金额:$72.31万
-
财政年份:2022
-
负责人:Mary McGrae McDermott
-
依托单位:
COCOA flavanols to improve walking performance in PAD: the COCOA-PAD II Trial
-
批准号:10430199
-
项目类别:
-
资助金额:$63.45万
-
财政年份:2021
-
负责人:Mary McGrae McDermott
-
依托单位:
COCOA flavanols to improve walking performance in PAD: the COCOA-PAD II Trial
-
批准号:10685352
-
项目类别:
-
资助金额:$58.37万
-
财政年份:2021
-
负责人:Mary McGrae McDermott
-
依托单位:
COCOA flavanols to improve walking performance in PAD: the COCOA-PAD II Trial
-
批准号:10209585
-
项目类别:
-
资助金额:$70.87万
-
财政年份:2021
-
负责人:Mary McGrae McDermott
-
依托单位:
COCOA PAD II Trial: Microbiome Ancillary Study
-
批准号:10610072
-
项目类别:
-
资助金额:$18.3万
-
财政年份:2021
-
负责人:Mary McGrae McDermott
-
依托单位:
Pilot/Exploratory Studies Core (PESC)
-
批准号:10455653
-
项目类别:
-
资助金额:$44.46万
-
财政年份:2020
-
负责人:Mary McGrae McDermott
-
依托单位:
Pilot/Exploratory Studies Core (PESC)
-
批准号:10220722
-
项目类别:
-
资助金额:$43.17万
-
财政年份:2020
-
负责人:Mary McGrae McDermott
-
依托单位:
APelin, EXercise, and mobility in Peripheral Artery Disease, the APEX-PAD Study
-
批准号:10092068
-
项目类别:
-
资助金额:$13.88万
-
财政年份:2020
-
负责人:Mary McGrae McDermott
-
依托单位:
Pilot/Exploratory Studies Core (PESC)
-
批准号:10670210
-
项目类别:
-
资助金额:$29.52万
-
财政年份:2020
-
负责人:Mary McGrae McDermott
-
依托单位:
1/2 + PROmote weight loss in obese PAD patients to preVEnt mobility loss: the PROVE Trial
-
批准号:10633185
-
项目类别:
-
资助金额:$65.01万
-
财政年份:2019
-
负责人:Mary McGrae McDermott
-
依托单位:
ConProject-001
-
批准号:10633186
-
项目类别:
-
资助金额:$3.36万
-
财政年份:2019
-
负责人:Mary McGrae McDermott
-
依托单位:
Unacylated Ghrelin to Improve FuncTioning in PAD: the GIFT Trial
-
批准号:9927974
-
项目类别:
-
资助金额:$20.22万
-
财政年份:2019
-
负责人:Mary McGrae McDermott
-
依托单位:
1/2 + PROmote weight loss in obese PAD patients to preVEnt mobility loss: the PROVE Trial
-
批准号:10026434
-
项目类别:
-
资助金额:$64.26万
-
财政年份:2019
-
负责人:Mary McGrae McDermott
-
依托单位:
国内基金
海外基金
登录
查看更多内容
补阳还五汤通过AGE-RAGE通路调控脓毒症免疫失衡的机制与转化研究
-
批准号:JCZRLH202601523
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:
-
依托单位:
靶向递送一氧化碳调控AGE-RAGE级联反应促进糖尿病创面愈合研究
-
批准号:JCZRQN202500010
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:
-
依托单位:
对香豆酸抑制AGE-RAGE-Ang-1通路改善海马血管生成障碍发挥抗阿尔兹海默病作用
-
批准号:2025JJ70209
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:雷芬芳
-
依托单位:
AGE-RAGE通路调控慢性胰腺炎纤维化进程的作用及分子机制
-
批准号:--
-
项目类别:面上项目
-
资助金额:--
-
批准年份:2024
-
负责人:万荣
-
依托单位:
甜茶抑制AGE-RAGE通路增强突触可塑性改善小鼠抑郁样行为
-
批准号:2023JJ50274
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2023
-
负责人:贺志明
-
依托单位:
蒙药额尔敦-乌日勒基础方调控AGE-RAGE信号通路改善术后认知功能障碍研究
-
批准号:--
-
项目类别:地区科学基金项目
-
资助金额:33万元
-
批准年份:2022
-
负责人:都义日
-
依托单位:
补肾健脾祛瘀方调控AGE/RAGE信号通路在再生障碍性贫血骨髓间充质干细胞功能受损的作用与机制研究
-
批准号:--
-
项目类别:面上项目
-
资助金额:52万元
-
批准年份:2022
-
负责人:叶宝东
-
依托单位:
LncRNA GAS5在2型糖尿病动脉粥样硬化中对AGE-RAGE 信号通路上相关基因的调控作用及机制研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:10.0万元
-
批准年份:2022
-
负责人:于海兵
-
依托单位:
围绕GLP1-Arginine-AGE/RAGE轴构建探针组学方法探索大柴胡汤异病同治的效应机制
-
批准号:81973577
-
项目类别:面上项目
-
资助金额:55.0万元
-
批准年份:2019
-
负责人:辛贵忠
-
依托单位:
AGE/RAGE通路microRNA编码基因多态性与2型糖尿病并发冠心病的关联研究
-
批准号:81602908
-
项目类别:青年科学基金项目
-
资助金额:18.0万元
-
批准年份:2016
-
负责人:刘括
-
依托单位: